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hticense.Abstract Background: Appropriate diagnostic methods for tuberculous pleural effusion are vital.
The IFN-c tests using speciﬁc Mycobacterium Tuberculos is antigens in samples from the site of
infection may be promising in diagnosis of tuberculosis. Objective we examined the ability of
ELISpot test using circulating peripheral blood mononuclear cells (PBMC) and compartmentalized
pleural ﬂuid mononuclear cells (PFMC) for diagnosis of active TB infection in patients with tuber-
culous pleural effusion. Methods PBMC and PFMC-based ELISpot test for IFN-c test using
speciﬁc M. tuberculosis antigen: Early Secretory Antigen Target-6 protein (ESAT-6) was used for
diagnosis of active TB infection. Thirty-ﬁve patients with clinically suspected tuberculous pleural
effusion were enrolled over a 12-month period. Results 11 patients out of 35 were positive by culture
and PCR (31.4%). Incubation of PBMC with ESAT-6 for 8 h showed sensitivity and speciﬁcity of
82% and 92%, respectively, for the PBMC–ELISpot as compared to PFMC–ELISpot that was
54% and 96% respectively. With 24 h incubation of ESAT-6 there was around 2.5 fold increase
in the median number of spot forming cells (SFCs) in PFMC from 30 to 74, whereas there was min-
imal increase of median number of SFCs in PBMC from 55 to 60. Conclusion ESAT-6 – ELISpot
using PBMC and PFMC is useful as a tool for diagnosis of TB effusion. PFMC needs longer period
of incubation for processing of ESAT-6 than PBMC. Moreover, IFN-c in pleural effusion (PE) is
another useful way for diagnosis of TB pleurisy which is sensitive, simple and cheap.
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Tuberculosis (TB) is a major public health problem and it is
estimated by the World Health Organization that there are
approximately 9.4 million incident cases, and 1.3 million
deaths among HIV-negative people [1]. The disease is espe-
cially prevalent in developing countries, where it accounts foris. Production and hosting by Elsevier B.V.
.10.012
140 W. Shouman et al.more than a quarter of all preventable adult deaths [2]. The
diagnosis of tuberculous pleural effusion remains a serious
clinical problem. Routine analysis of pleural ﬂuid, signs and
symptoms and radiological ﬁnding are often inadequate for
starting of empirical therapy.
Currently, the only sure criterion for deﬁnite diagnosis of
TB is the demonstration of the presence of tubercle bacilli in
clinical specimens. This is based on traditional methods: the
Ziehl-Neelsen (ZN) acid fast stain and laboratory culture of
Mycobacterium tuberculosis on Lowenstein Jensen media (LJ)
medium. However, ZN stains lacks speciﬁcity and sensitivity,
whilst conﬁrmation by culture requires several weeks [3].
Although, new rapid diagnostic culture methods have been
investigated that are based on either bacteriophage detection
methods [4] or liquid culture technique such as BACTEC [5],
they require specialized personnel and equipment. In addition
their expenses have limited their use in many routine diagnos-
tic laboratories.
Several newly developed diagnostic assays for TB based on
M. tuberculosis – speciﬁc antigens encoded by genes in the re-
gion of difference 1 (RD1 region) gave promising results for
diagnosis of M. tuberculosis infection. These speciﬁc antigens
such as early secreted antigenic target-6 (ESAT-6) and culture
ﬁltrate protein-10 (CFP-10) are proved to be accurate marker
of M. tuberculosis infection and to distinguish M. tuberculosis
infection from the response to BCG vaccination [6].
ESAT-6 and CFP-10 forms 1:1 complex when co expressed
in an engineered BCG strains which found to be difﬁcult to be
processed and presented to T Cells. Consequently, single anti-
gen is preferred to be used rather than ESAT-6 and CFP-10
form [7]. ESAT-6 or CFP-10 have been frequently used in En-
zyme-linked immunospot (ELISpot) [8–10], Flow-cytometry
[7,11–14] and Quantiferon assays [15,16]. The usefulness of
these assays for diagnosis of tuberculous pleural effusion in ac-
tual clinical practice is limited especially in endemic area. It has
been shown that mononuclear cells (MC) compartmentalized
in the infected sites such as pleural ﬂuid [17], bronchoalveolar
lavage ﬂuid [18] and CSF [12,19] secrets higher IFN-c in in-
fected sites than peripheral blood mononuclear cells.
In this study we aimed to evaluate the ability of ELISpot
test using circulating peripheral blood mononuclear cells
(PBMC) and compartmentalized pleural ﬂuid mononuclear
cells (PFMC) for diagnosis of active TB infection in patients
with tuberculous pleural effusion.Figure 1 IFN-c producing T-cell responses (A) (Negative
control), (B) (Positive Control) and (C) (ESAT-6).Materials and methods
This study was done at Chest and Microbiology & Immunol-
ogy Departments, Zagazig University Hospitals between
November 2009 and October 2010. Written informed consents
were taken from all subjects.
Thirty-ﬁve patients with suspected TB pleural effusion
(ages 37 ± 11.2 years, male/female = 24/11) were included.
The following were done:
(1) Full clinical examination.
(2) Plain chest X ray and chest CT
(3) Pleural ﬂuid tapping was performed according to the
standards procedures (20). Cytological, microbiological
ZN stain, culture, and pleural ﬂuid PCR were processed
using standard techniques [8,12].(4) Thoracoscopy and/or Abram’s pleural biopsy was per-
formed to cases in which ﬁnal diagnosis was not reached
by the previous procedures.
(5) A total of nineteen patients with non-tuberculous pleu-
ral effusion were enrolled as a control in this study (ages
32 ± 7 years, male/female = 15/4).
Antigen
ESAT-6 was produced as recombinant proteins in Escherichia
coli (13).
Table 1 Clinical features of patients enrolled (n= 35).
Number
Features:
Male 24 (68.5%)
Female 11 (32.2%)
Age 37 ± 11.2
Chest X-ray inﬁltrates 4 (11.4%)
Clinical Symptoms:
Cough 14 (40%)
Expectoration 10 (28.5%)
Haemoptysis 3 (8.5%)
Breathlesnes 27 (77.1%)
Chest pain 15 (20%)
Fever 9 (25.7%)
Weight loss 17 (48.5%)
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MTB-speciﬁc assay was performed using test–plates from R &
D systems (EL285-Human IFN-c ELISpot Kit). PBMC and
PFMC were prepared by Ficoll-Hypaque gradient centrifuga-
tions from 5-ml heparinised blood and 50 ml to 75 ml pleural
ﬂuid respectively. Brieﬂy, 250,000 PBMC or 250,000 PFMC
were plated on two plates pre-coated with anti-human IFN-c
antibody after stimulation with ESAT-6 peptide (5 lg/ml ﬁnal
concentration). One plate was incubated for 8 h. and the other
one was incubated for 24 h. at 37 C in a humid atmosphere of
5% CO2. Spots-counting and analysis were performed accord-
ing to manual’s instruction. For each sample, negative control
sample (unstimulated) and a positive control (stimulated with
phorbol myrisate acetate (P-1585, Sigma) at a ﬁnal concentra-
tion of 20 ng/ ml and Ionomycin (I-0634, Sigma) at 1 lM were
included Figure 1. The test was scored positive if the average
number of SFCs was higher than the average number of SFCs
in controls using ROC curve test. Background number of spots
in negative control was always less than 10 and positive control
more than 50.
PE – IFN-c
IFN-c in pleural effusion (PE) was measured using ELISA kit
(Biosource Europe, Belgium).
Tuberculin Skin test (TST)
The TST is performed by injecting 0.1 ml of tuberculin puriﬁed
protein derivative (PPD) into the inner surface of the forearm
intradermally. The skin test reaction read between 48 and 72 h
after administration.
Statistical analysis
Statistical analysis was performed by SPSS (SPSS Inc., Chicago,
II, USA). TheMann-Whitney andROC curve test were used for
comparison in the patient group between different tests.
Results
Thirty-ﬁve patients with suspected tuberculous pleural effusion
were prospectively enrolled in this study. Eleven patients had
deﬁnite diagnosis of tuberculous pleural effusion either by cul-
ture or PCR or presence of caseating granuloma in the pleural
biopsy taken by Abram’s blind needle biopsy or thoracoscopy.
The other 24 patients were considered to have presumptive
tuberculosis. Clinical characteristics of the patients’ group
are shown in Table 1. Nineteen controls with non – tubercu-
lous pleural effusion; 12 parapeumonic, 6 malignant and 1
with hepatic hydrothorax were included.
Among all of the 11 patients with conﬁrmed tuberculous
pleural effusion, the ELISpot TB were positive in (9/11)
81.8% in PBMCs (median number of SFCs was 60 out of
250,000 T cells) and (6/11) 54.5% in PFMCs (median number
of SFCswas 40 out of 250,000T cells)Figure 2. In the 24 patients
with presumptive diagnosis of TBPE, the ELISpot TB were po-
sitive in 3/24 (12.5%) in PBMC and 1/24 (4%) in PFMC.More-over, the median number of SFCs was 20 out of 250,000 T cells
for both PBMCs and PFMCs. Themedian number of SFCs was
20 and 18 for PBMCs and PFMCs respectively in the control
group. The number of SCFs in PBMCs and PFMCs was statis-
tically different between controls and patients with conﬁrmed
tuberculosis (p< 0.001). The sensitivity and speciﬁcity of
ESAT-6-ELISpot for the diagnosis of TBPE was 82% 92%,
respectively, for PBMCs whereas those for PFMC were 54%
and 96% respectively (Table 2).
In the 11 conﬁrmed cases, the PBMC ELISpot results did
not correlate with PFMC in ﬁve cases: four cases were positive
by PBMC (one of them gave borderline results and the other
three were negative by PFMC), the ﬁfth case gave positive re-
sult by PFMC and was negative by PBMC. This case was also
positive by PCR.
To demonstrate the effect of the time of incubation in activa-
tion of primed T cells. The separated PBMCandPFMC from10
patients were cultured for 24 h in the presence of ESAT-6 and
IFN-c production was assessed by ELISpot test. The median
number of SFCs increased from 55 to 60 in PBMCs whereas
there was a signiﬁcant increase in the median number of SFCs
in PFMCs from 30 to 74 after the addition of ESAT-6 for 24 h
Figure 3. With 24 h incubation, the sensitivity and speciﬁcity
of both PBMC and PFMC were 100% and 60% respectively.
In comparison, the 8 h culture PBMC had sensitivity and spec-
iﬁcity of 100% and 60% whereas, these of PFMCs were 40%
and 80% respectively for the same 10 patients (Table 3).
The size of indurations of TST did not match with the
intensity of SFC. Moreover, TST had a sensitivity of 70%
which is lower than that of PBMC–ELISpot (82%) and higher
than that of PFMC (54%). However, the speciﬁcity of TST
(88%) was lower than both PBMC–ELISpot (92%) and
PFMC (96%).
Four patients out of 35 gave intermediate ELISpot result
(around 30 spots) by both PBMC and PFMC: The culture
was negative for those four patients but there was only one pa-
tient had positive tuberculin and PCR results.
Pleural ﬂuid IFN-c level in 11 patients with conﬁrmed po-
sitive cases and presumptive TBPE were 5.5 and 1.0 pg/ml,
respectively, whereas this for non tuberculous effusion was
0.45. There was signiﬁcant difference between the three groups
(p 6 0.01). Interestingly, there was one case which was positive
by TST, PBMC and PFMC and PE – IFN-c and was negative
by both culture and PCR.
Figure 2 Concentration of ESAT-6 – IFN-c producing SFCs after 8 h incubation in PBMCs or PFMCs of 35 patients with suspected
pleural tuberculosis.
Table 2 Sensitivity and Speciﬁcity of different tests among 35
cases with suspected TBPE after 8hrs incubation of ESAT-6.
Test No of
positive cases
Sensitivity
(%)
Speciﬁcity
(%)
ESAT-6 PBMC (8 h) 12 (35) 82 92
ESAT-6 PFMC (8 h) 7 (35) 54 96
IFN–c in PE 10 (35) 85.7 95.6
Table 3 Comparison of 8 h and 24 h. incubations of ESAT-6
among 10 random cases with suspected tuberculous pleural
effusion.
Test No of
positive cases
Sensitivity
(%)
Speciﬁcity
(%)
ESAT-6 PBMC (8 hrs) 7(10) 100 60
ESAT-6 PFMC (8 h) 3(10) 40 80
ESAT-6 PBMC (24 h) 7 (10) 100 60
ESAT-6 PFMC (24 h) 7(10) 100 60
142 W. Shouman et al.PBMCs or PFMCs of random 10 patients with suspected
pleural tuberculosis.
Discussion
IFN-c based assays have been studied in the diagnosis of extra-
pulmonary TB [17,19–22]. In tuberculous pleural effusion anti-
gen speciﬁc memory T-lymphocytes migrate from blood to the
site of infection and release T-helper cell cytokines up on con-
tact with antigens. Diagnosis of TB from antigen speciﬁc T-
cells cytokines release have been extensively studied using
RD-1 encoded antigens such as ESAT-6 and CFP-10. More-
over, it is showed that the sensitivity and speciﬁcity of
ESAT-6 antigen alone is higher than CFP-10 and ESAT-6+
CFP10. While antigen-speciﬁc–T-cells cytokines release assays
in blood have better sensitivity and speciﬁcity than otherFigure 3 Concentration of ESAT-6 – IFN-c producing SFCs after 2
suspected pleural tuberculosis.assays such as tuberculin skin test (TST), they cannot distin-
guish between active and latent TB. Furthermore, it has been
demonstrated that using antigen-speciﬁc T-cells cytokines re-
lease assays directly on mononuclear cells from the site of
infection has better performance in the diagnostic ability in
discrimination between active and latent infection (12).
However, there are no detailed studies in our area on the
diagnostic ability of the ESAT-6-speciﬁc T-cells cytokines re-
lease assays in discrimination between active and latent infec-
tion. Also, there is no adequate evidence on effect of
incubation time and processing of antigens on production of
the antigen-speciﬁc-cells cytokines.4 h incubation in PBMCs or PFMCs of random 10 patients with
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sion by enumerating ESAT-6 – speciﬁc T-cells from the periph-
eral blood and pleural ﬂuid was evaluated. In conﬁrmed TB
positive patients the mean numbers of ESAT-6–SFCs in
PBMC ELISpot was higher than that of PFMC ELISpot by
1.5 fold. With 8 h of incubation, our result is similar to that
of Baba and his colleagues [16], who found that QFT–TB in
blood was higher than that of pleural ﬂuid with sensitivity of
71% and 44% respectively. However, this result is not in
agreement with study done by Losi and his colleagues [8],
who found that PFMC has a high sensitivity of 95% which
is 7.5% higher than PBMC suggesting a compartmentalization
of antigen-speciﬁc T-cells in TBPE. The possible explanation
may be explained by the different ethnic background of pa-
tients and different kits (T Spot.TB Kit) in Losi’s study.
The ESAT-6-ELISpot speciﬁcity in our study was 82% and
96% for both PBMC and PFMC respectively. Three out of 35
patients had a false positive result. One of these patients was
false positive by PBMC and PFMC and positive by TST as
well had a history of treatment of tuberculosis. One patient
was positive by PFMC and PCR and negative by PBMC–ELI-
Spot assay. This patient was cured by antituberculous drugs.
This speciﬁcity test was higher than that of Losi and colleagues
who reported 76%.
The SFC increased by about 2.5 fold in PFMC when incu-
bation time increased from 8 h to 24 h However, there was
slight increase in the no of SFC in PBMC. The results show
that increase time of incubation allows longer time for anti-
gen processing by monocytes in PFMC for digestion of pep-
tide. Moreover, increase time of incubation may have
differential expression of cytokines proﬁle between PBMC
and PFMC.
Measurement of whole IFN-c in the pleural ﬂuid has been
used as diagnostic markers for tuberculous pleural effusion
[23]. In this study, IFN-c in pleural ﬂuid has sensitivity of
85.7 and speciﬁcity of 95.6 which is comparable to that of
Hiraki [23]. The sensitivity of IFN-c was the same as that of
ELISpot PBMC (85.75) and higher than that of PFMC
(71.4). The speciﬁcity of IFN-c in pleural ﬂuid was higher than
that of PBMC–ELISpot (85.7 vs (82%) & similar to that of
PFMC-ELISpot (96%).Conclusion
ESAT-6-ELISpot using PBMC and PFMC is useful adjunct
tool for diagnosis of TB effusion. However, PFMC needs long-
er period of incubation for processing of ESAT-6 than PFMC.
Moreover, IFN-c in pleural ﬂuid is another useful way for
diagnosis of TB pleurisy which is sensitive, simple and cheap.
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